In developing eye diseases, e.g., AMD and ROP, the level of VEGF is elevated, which suggests that inhibition of the VEGF-mediated angiogenesis could be a possible therapeutic approach for these eye diseases [36]. The gene discussed is VEGFA; the disease is eye disorder.